Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-02

Clinical Trial Update: Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluated heme iron polypeptide for iron-deficiency anemia in chronic kidney disease; the study is completed and results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heme iron polypeptide (heme iron polypeptide)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Anemia, Renal Failure | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-05-02